nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.07.2012 | Article

Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections

verfasst von: E. Paradowska, M. Studzińska, D. Nowakowska, J. Wilczyński, M. Rycel, P. Suski, Z. Gaj, B. Kaczmarek, Z. Zbróg, Z. J. Leśnikowski

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Human cytomegalovirus (HCMV) is the most common congenital infection. HCMV strains display genetic variability in different regions. Distribution of HCMV genotypes in the population of congenitally infected newborns from Central Poland and viral load in newborns’ blood is described and discussed. HCMV isolates were analysed by sequencing at three sites on the genome: the UL144 tumour necrosis factor-alpha (TNFα)-like receptor gene, the US28 beta-chemokine receptor gene and the UL55 envelope glycoprotein B (gB) gene. The newborns’ blood was examined for HCMV DNA with a nested (UL144, UL55) or heminested (US28) polymerase chain reaction, and the genotypes were determined by sequence analysis. HCMV DNA was detectable in 25 out of 55 examined newborns born by HCMV-infected mothers (45.5%). The blood viral load in mother–infant pairs was determined. Most of the newborns had identical virus genotype, gB2 (96%), UL144 B1 (88%) and US28 A2 (84%). These genotypes were detected in all newborns with asymptomatic congenital infection. The occurrence of UL144 B1 or US28 A2 genotypes in the babies examined was significant in comparison to other genotypes (p = 0.0002 and p = 0.040 respectively). There was no association between specific gB subtypes in all patients groups (p = 0.463). There was no correlation between HCMV genotypes and the outcome.

Griffiths PD (2002) Strategies to prevent CMV infection in the neonate. Semin Neonatol 7(4):293–299. doi:10.1053/siny.2002.0123 PubMed

Britt W (2007) HCMV: pathogenesis and disease consequences. In: Arvin A, Campadelli-Fiume G, Mocarski E, Roizman B, Whitley R, Yamanishi K (eds) Human herpesviruses: biology, therapy, and immunoprophylaxis, vol 1. Cambridge University Press, Cambridge

Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD et al (1982) Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Eng J Med 306(16):945–949CrossRef

Adler SP, Nigro G, Pereira L (2007) Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Sem Perinat 31(1):10–18. doi:10.1053/j.semperi.2007.01.002 CrossRef

Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S (2006) Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 35(2):216–220. doi:10.1016/j.jcv.2055.09.015 PubMedCrossRef

Gouarin S, Gault E, Vabret A, Cointe D, Rozenberg F, Grangeot-Keros L et al (2002) Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol 40(5):1767–1772. doi:10.1128/JCM.40.5.1767-1772.2002 PubMedCrossRef

Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS et al (2006) Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis 194(4):464–473. doi:10.1086/505427 PubMedCrossRef

Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B et al (2006) Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 117(1):e76–e83. doi:10.1542/peds.2005-0629 PubMedCrossRef

Paradowska E, Przepiórkiewicz M, Nowakowska D, Studzińska M, Wilczyński J, Emery VC et al (2006) Detection of cytomegalovirus infection in human placental cells by polymerase chain reaction. APMIS 114(11):764–771. doi:10.1111/j.1600-0463.2006.apm_31.x PubMedCrossRef

10.

Chou S, Dennison KM (1991) Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 163(6):1229–1234. doi:10.1093/infdis/163.6.1229 PubMedCrossRef

11.

Meyer-König U, Vogelberg C, Bongarts A, Kampa D, Delbrück R, Wolff-Vorbeck G et al (1998) Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 55(1):75–81. doi:10.1002/(SICI)1096-9071(199805 PubMedCrossRef

12.

Meyer-König U, Haberland M, von Laer D, Haller O, Hufert FT (1998) Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 177(5):1162–1169. doi:10.1086/515262 PubMedCrossRef

13.

Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF (2011) Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog 7(5):e1001344. doi:10.1371/journal.ppat.1001344 PubMedCrossRef

14.

Arav-Boger R, Willoughby RE, Pass RF, Zong JC, Jang WJ, Alcendor D et al (2002) Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor alpha and beta chemokine receptors in congenital CMV disease. J Infect Dis 186(8):1057–1064. doi:10.1086/344238 PubMedCrossRef

15.

Bale JF, Petheram SJ, Robertson M, Murph JR, Demmler G (2001) Human cytomegalovirus A sequence and UL144 variability in strains from infected children. J Med Virol 65(1):90–96. doi:10.1002/jmv.2006 PubMedCrossRef

16.

Mao ZQ, He R, Sun M, Qi Y, Huang YJ, Ruan Q (2007) The relationship between polymorphisms of HCMV UL144 ORF and clinical manifestations in 73 strains with congenital and/or perinatal HCMV infection. Arch Virol 152(1):115–124. doi:10.1007/s00705-006-0826-8 PubMedCrossRef

17.

Picone O, Costa J-M, Chaix M-L, Ville Y, Rouzioux C, Leruez-Ville M (2005) Human cytomegalovirus UL144 gene polymorphisms in congenital infections. J Clin Microbiol 43(1):25–29. doi:10.1128/JCM.43.1.25-29.2005 PubMedCrossRef

18.

Stranska R, Schuurman R, Toet M, Verboon-Maciolek M, de Vries LS, van Loon AM (2006) Application of UL144 molecular typing to determine epidemiology of cytomegalovirus infections in preterm infants. J Clin Microbiol 44(3):1108–1110. doi:10.1128/JCM.44.3.1108-1110.2006 PubMedCrossRef

19.

Lurain NS, Kapell KS, Huang DD, Short JA, Paintsil J, Winkfield E et al (1999) Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol 73(12):10040–10050PubMed

20.

Arav-Boger R, Foster CB, Zong JC, Pass RF (2006) Human cytomegalovirus-encoded alpha chemokines exhibit high sequence variability in congenitally infected newborns. J Infect Dis 193(6):788–791. doi:10.1086/500508 PubMedCrossRef

21.

Arista S, De Garcia S, Giammanco GM, Di Carlo P, Iannitto E (2003) Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations. Arch Virol 148(3):547–554. doi:10.1007/s00705-002-0941-0 PubMedCrossRef

22.

Bale JF, Murph JR, Demmler GJ, Dawson J, Miller JE, Petheram SJ (2000) Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis 182(3):933–936. doi:10.1086/315770 PubMedCrossRef

23.

Barbi M, Binda S, Caroppo S, Primache V, Didò P, Guidotti P et al (2001) CMV gB genotypes and outcome of vertical transmission study on dried blood spots of congenitally infected babies. J Clin Virol 21(1):75–79. doi:10.1016/S1386-6532(00)00188-8 PubMedCrossRef

24.

Jin H, Wang X, Li S (2007) Human cytomegalovirus glycoprotein B genotype correlates with different symptoms of infected infants. Intervirology 50(3):219–223. doi:10.1159/000100564 PubMedCrossRef

25.

Lukácsi A, Taródi B, Endreffy E, Bábinszki A, Pál A, Pusztai R (2001) Human cytomegalovirus gB genotype 1 is dominant in congenital infections in south Hungary. J Med Virol 65(3):537–542. doi:10.1002/jmv.2070 PubMedCrossRef

26.

Trincado DE, Scott G, White A, Hunt C, Rasmussen L, Rawlinson WD (2000) Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 61(4):481–487. doi:10.1002/1096-9071(200008)61:4 PubMedCrossRef

27.

Yamamoto AY, Mussi-Pinhata MM, de Deus Wagatsuma VM, Marin LJ, Duarte G, Figueiredo LT (2007) Human cytomegalovirus glycoprotein B genotypes in Brazilian mothers and their congenitally infected infants. J Med Virol 79(8):1164–1168. doi:10.1002/jmv.20903 PubMedCrossRef

28.

Pignatelli S, Dal Monte P, Rossini G, Lazzarotto T, Gatto MR, Landini MP (2003) Intrauterine cytomegalovirus infection and glycoprotein N (gN) genotypes. J Clin Virol 28(1):38–43. doi:10.1016/S1386-6532(02)00236-6 PubMedCrossRef

29.

Benedict CA, Butrovich KD, Lurain NS, Corbeil J, Rooney I, Schneider P et al (1999) Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162(12):6967–6970PubMed

30.

Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW et al (1999) Cytomegalovirus encodes a potent chemokine. Proc Natl Acad Sci USA 96(17):9839–9845PubMedCrossRef

31.

Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L et al (1998) Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188(5):855–866PubMedCrossRef

32.

Casarosa P, Waldhoer M, LiWang PJ, Vischer HF, Kledal T, Timmerman H et al (2005) CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor. J Biol Chem 280(5):3275–3285. doi:10.1074/jbc.M407536200 PubMedCrossRef

33.

Gao J-L, Murphy PM (1994) Human cytomegalovirus open reading frame US28 encodes a functional β chemokine receptor. J Biol Chem 269(46):28539–28542PubMed

34.

Kuhn DE, Beall CJ, Kolattukudy PE (1995) The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem Biophys Res Commun 211(1):325–330. doi:10.1006/bbrc.1995.1814 PubMedCrossRef

35.

Boomker JM, The TH, de Leij LF, Harmsen MC (2006) The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer. Virus Res 118(1):196–200. doi:10.1016/j.virusres.2005.12.011 PubMedCrossRef

36.

Pleskoff O, Tréboute C, Alizon M (1998) The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins. J Virol 72(8):6389–6397PubMed

37.

Pleskoff O, Casarosa P, Verneuil L, Ainoun F, Beisser P, Smit M et al (2005) The human cytomegalovirus-encoded chemokine receptor US28 induces caspase-dependent apoptosis. FEBS J 272(16):4163–4177. doi:10.1111/j.1742-4658.2005.04829.x PubMedCrossRef

38.

Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR (1996) Human cytomegalovirus clinical isolates carry at least 19 genes not fund in laboratory strains. J Virol 70(1):78–83PubMed

39.

Zipeto D, Hong C, Gerna G, Zavattoni M, Katzenstein D, Merigan TC et al (1998) Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1–4 in immunocompromised patients. AIDS Res Hum Retrovir 14(6):533–536PubMedCrossRef

40.

Hassan-Walker A, Mattes FM, Griffiths PD, Emery VC (2001) Quantity of cytomegalovirus DNA in different leukocyte populations during active infection in vivo and the presence of gB and UL18 transcripts. J Med Virol 64:283–289. doi:10.1002/jmv.1048 PubMedCrossRef

41.

Temperton NJ, Quenelle DC, Lawson KM, Zuckerman JN, Kern ER, Griffiths PD et al (2003) Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides. J Med Virol 70:86–90. doi:10.1002/jmv.10357 PubMedCrossRef

42.

Halwachs-Baumann G, Genser B, Pailer S, Engele H, Rosegger H, Schalk A et al (2002) Human cytomegalovirus load in various body fluids of congenitally infected newborns. J Clin Virol 25 [Suppl 3]:S81–S87. doi:10.1016/S1386-6532(02)00188-9 PubMedCrossRef

43.

Rybka K, Orzechowska B, Siemieniec I, Leszek J, Zaczyńska E, Pająk J, Błach-Olszewska Z (2003) Age related natural antiviral non-specific immunity of human leukocytes. Med Sci Monit 9(12):BR413–BR417PubMed

44.

Paradowska E, Blach-Olszewska Z, Gejdel E (1997) Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta 18:441–446PubMedCrossRef

45.

Paradowska E, Błach-Olszewska Z, Sender J, Jarosz W (1996) Antiviral nonspecific immunity of human placenta at term: possible role of endogenous tumor necrosis factors and interferons. J Interferon Cytokine Res 16:941–948PubMedCrossRef

46.

Waters A, Hassan J, deGascun C, Kissoon G, Knowles S, Molloy E et al (2010) Human cytomegalovirus UL144 is associated with viremia and infant development sequel in congenital infection. J Clin Microbiol 48(11):3956–3962. doi:10.1128/JCM.01133-10 PubMedCrossRef

47.

Heo J, Petheram S, Demmler G, Murph JR, Adler SP, Bale J et al (2008) Polymorphisms within human cytomegalovirus chemokine (UL146/147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children. Virology 378(1):86–96. doi:10.1016/j.virol.2008.05.002 PubMedCrossRef

48.

Davison AJ, Dolan A, Akter P, Addison C, Dargan DJ, Alcendor DJ et al (2003) The human cytomegalovirus genome revisited: comparison with chimpanzee cytomegalovirus genome. J Gen Virol 84(4):17–28. doi:10.1099/vir.0.18606-0 PubMedCrossRef

49.

Arav-Boger R, Boger YS, Foster CB, Boger Z (2008) The use of artificial neural networks in prediction of congenital CMV outcome from sequence data. Bioinform Biol Insights 2:281–289PubMed

50.

Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O et al (2006) Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci USA 103(35):13068–13073. doi:10.1073/pnas.0604433103 PubMedCrossRef

51.

Maussang D, Langemeijer E, Fitzsimons CP, Stigter-van Walsum M, Dijkman R, Borg MK et al (2009) The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res 69(7):2861–2869. doi:10.1158/0008-5472.CAN-08-2487 PubMedCrossRef

52.

Picone O, Costa JM, Leruez-Ville M, Ernault P, Olivi M, Ville Y (2004) Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected foetuses. Prenat Diagn 24(12):1001–1006. doi:10.1002/pd.942 PubMedCrossRef

53.

Yan H, Koyano S, Inami Y, Yamamoto Y, Suzutani T, Mizuguchi M et al (2008) Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol 153(4):667–674. doi:10.1007/s00705-008-0044-7 PubMedCrossRef

54.

Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G (2004) Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 39(2):155–161. doi:10.1086/421496 PubMedCrossRef

55.

Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM, de Frizzo Oliveira P et al (2010) Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 202(3):297.e1–297.e8. doi:10.1016/j.ajog.2009.11.018 CrossRef

Titel: Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections
verfasst von: E. Paradowska
M. Studzińska
D. Nowakowska
J. Wilczyński
M. Rycel
P. Suski
Z. Gaj
B. Kaczmarek
Z. Zbróg
Z. J. Leśnikowski
Publikationsdatum: 01.07.2012
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-011-1447-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2012

A comparative study of two different methods of sample preparation for positive blood cultures for the rapid identification of bacteria using MALDI-TOF MS

Use of linezolid in neonatal and pediatric inpatient facilities—results of a retrospective multicenter survey

In vivo evaluation of a metronidazole-containing gel for the adjuvant treatment of chronic periodontitis: preliminary results

Clinical management of ESBL-producing Enterobacteriaceae: the insidious role of fluoroquinolones

Aggregatibacter actinomycetemcomitans serotypes infections and periodontal conditions: a two-way assessment

Hepatitis C virus infection among transmission-prone medical personnel

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin